We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
You must tell DVLA if you have obstructive sleep apnoea syndrome (OSAS) or any sleep condition or apnoea which causes excessive sleepiness.
Looking into how some factors that can influence the performance of people on board can lead to more accidents as well as how to mitigate or control these factors.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for clinicians and patients.
Facts about driving and tiredness when you have a medical condition.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
Find out about the long-term effects some people can have after having COVID-19.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Guidance documents and updates for Sellafield Ltd employees.
Employers guide to assessing fitness to work, including asking for medical evidence, fit notes, and dealing with long term or frequent absences.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).